{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:01:36Z","timestamp":1786982496371,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12664-025-01831-2","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T05:30:28Z","timestamp":1752903028000},"page":"556-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical utility of thiopurine metabolite levels in monitoring patients with inflammatory bowel disease: A single-centre retrospective study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-940X","authenticated-orcid":false,"given":"Khushboo G.","family":"Upadhyay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4914-2440","authenticated-orcid":false,"given":"Mihika B.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-5549","authenticated-orcid":false,"given":"Devendra C.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-8604","authenticated-orcid":false,"given":"Prasad R.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1703-5990","authenticated-orcid":false,"given":"Swarup A. V.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-180X","authenticated-orcid":false,"given":"Minal U.","family":"Paradkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita D.","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0604-3306","authenticated-orcid":false,"given":"Philip","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish G.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutan D.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanashri N.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-0819","authenticated-orcid":false,"given":"Tester F.","family":"Ashavaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-3798","authenticated-orcid":false,"given":"Alpa J.","family":"Dherai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"1831_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S0140-6736(71)90268-6","volume":"298","author":"JMT Willoughby","year":"1971","unstructured":"Willoughby JMT, Beckett J, Kumar PJ, Dawson AM. Controlled trial of azathioprine in Crohn\u2019s disease. Lancet. 1971;298:944\u20137.","journal-title":"Lancet."},{"key":"1831_CR2","doi-asserted-by":"crossref","unstructured":"Zhang F, Gao X, Ding L, et al. Prospective evaluation of pharmacogenomics and metabolite measurements upon azathioprine therapy in inflammatory bowel disease: an observational study.\u00a0Medicine (Baltimore). 2016;95:e3326.","DOI":"10.1097\/MD.0000000000003326"},{"key":"1831_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4137\/CGast.S5256","volume":"4","author":"BL Love","year":"2011","unstructured":"Love BL, Smith LS, Sarbah SA, Fowler FC. Azathioprine and infliximab: monotherapy or combination therapy in the treatment of Crohn\u2019s disease. Clin Med Gastroenterol. 2011;4:4.","journal-title":"Clin Med Gastroenterol."},{"key":"1831_CR4","doi-asserted-by":"crossref","unstructured":"Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease: current management. J Crohns Colitis. 2010;4:28\u201362.","DOI":"10.1016\/j.crohns.2009.12.002"},{"key":"1831_CR5","doi-asserted-by":"crossref","unstructured":"Ooi CJ, Makharia GK, Hilmi I, et al. Asia-Pacific consensus statements on Crohn\u2019s disease. Part 2: Management. J Gastroenterol Hepatol. 2016;31:56\u201368.","DOI":"10.1111\/jgh.12958"},{"key":"1831_CR6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jgh3.12798","volume":"6","author":"JQ Yeo","year":"2022","unstructured":"Yeo JQ, Cheen HHM, Wong A, et al. Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore. JGH Open. 2022;6:658\u201366.","journal-title":"JGH Open."},{"key":"1831_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","volume":"118","author":"MC Dubinsky","year":"2000","unstructured":"Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705\u201313.","journal-title":"Gastroenterology."},{"key":"1831_CR8","doi-asserted-by":"crossref","unstructured":"Relling MV, Schwab M, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2018 update. Clin Pharmacol Ther. 2019;105:1095\u2013105.","DOI":"10.1002\/cpt.1304"},{"key":"1831_CR9","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.crohns.2011.12.003","volume":"6","author":"LP Gilissen","year":"2012","unstructured":"Gilissen LP, Wong DR, Engels LG, et al. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. J Crohns Colitis. 2012;6:698\u2013707.","journal-title":"J Crohns Colitis."},{"key":"1831_CR10","first-page":"505","volume":"4","author":"MP Sparrow","year":"2008","unstructured":"Sparrow MP. Use of allopurinol to optimize thiopurine immunomodulator efficacy in inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2008;4:505\u201311.","journal-title":"Gastroenterol Hepatol (N Y)."},{"key":"1831_CR11","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1002\/ibd.21458","volume":"17","author":"ML Haines","year":"2011","unstructured":"Haines ML, Ajlouni Y, Irving PM, et al. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1301\u20137.","journal-title":"Inflamm Bowel Dis."},{"key":"1831_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.cgh.2006.11.020","volume":"5","author":"MP Sparrow","year":"2007","unstructured":"Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007;5:209\u201314.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1831_CR13","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.dld.2021.05.038","volume":"53","author":"P Sousa","year":"2021","unstructured":"Sousa P, Ministro P, Armuzzi A, et al. Thiopurines: use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease. Dig Liver Dis. 2021;53:1571\u20139.","journal-title":"Dig Liver Dis."},{"key":"1831_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/jgh3.12004","volume":"1","author":"SP Parkar","year":"2017","unstructured":"Parkar SP, Dherai AJ, Desai DC, Ashavaid TF. Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease. JGH Open. 2017;1:25\u2013131.","journal-title":"JGH Open."},{"key":"1831_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/flgastro-2016-100738","volume":"9","author":"B Warner","year":"2018","unstructured":"Warner B, Johnston E, Arenas-Hernandez M, et al. A practical guide to thiopurine prescribing and monitoring in IBD. Frontline Gastroenterol. 2018;9:10\u20135.","journal-title":"Frontline Gastroenterol"},{"key":"1831_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","volume":"22","author":"G Bastida","year":"2005","unstructured":"Bastida G, Nos P, Aguas M, et al. Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;22:775\u201382.","journal-title":"Aliment Pharmacol Ther."},{"key":"1831_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s40272-020-00411-5","volume":"22","author":"K van Hoeve","year":"2020","unstructured":"van Hoeve K, Vermeire S. Thiopurines in pediatric inflammatory bowel disease: current and future place. Pediatr Drugs. 2020;22:449\u201361.","journal-title":"Pediatr Drugs"},{"key":"1831_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis. 2014;8:1179\u2013207.","journal-title":"J Crohns Colitis."},{"key":"1831_CR19","doi-asserted-by":"crossref","unstructured":"Feuerstein JD, Nguyen GC, Kupfer SS, et al.\u00a0American gastroenterological association institute guideline on therapeutic drug monitoring in inflammatory bowel disease. Gastroenterology. 2017;153:827\u201334.","DOI":"10.1053\/j.gastro.2017.07.032"},{"key":"1831_CR20","doi-asserted-by":"crossref","unstructured":"Vande Casteele N, Herfarth H, Katz J, Falck-Ytter Y, Singh S. American Gastroenterological Association Institute Technical Review on the role of therapeutic drug monitoring in the management of inflammatory bowel diseases.\u00a0Gastroenterology. 2017;153:835\u201357.e6.","DOI":"10.1053\/j.gastro.2017.07.031"},{"key":"1831_CR21","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","volume":"2","author":"MC Dubinsky","year":"2004","unstructured":"Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol. 2004;2:731\u201343.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1831_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/j.1365-2036.2007.03278.x","volume":"25","author":"CY Ooi","year":"2007","unstructured":"Ooi CY, Bohane TD, Lee D, Naidoo D, Day AS. Thiopurine metabolite monitoring in paediatric inflammatory bowel disease. Aliment Pharmacol Ther. 2007;25:941\u20137.","journal-title":"Aliment Pharmacol Ther."},{"key":"1831_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S1542-3565(04)00127-2","volume":"2","author":"C Cuffari","year":"2004","unstructured":"Cuffari C, Dassopoulos T, Turnbough L, Thompson RE, Bayless TM. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2:410\u20137.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1831_CR24","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","volume":"130","author":"MT Osterman","year":"2006","unstructured":"Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006;130:1047\u201353.","journal-title":"Gastroenterology."},{"key":"1831_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/jgh.14465","volume":"34","author":"R Feng","year":"2019","unstructured":"Feng R, Guo J, Zhang SH, et al. Low 6-thioguanine nucleotide level: effective in maintaining remission in Chinese patients with Crohn\u2019s disease. J Gastroenterol Hepatol. 2019;34:679\u201385.","journal-title":"J Gastroenterol Hepatol."},{"key":"1831_CR26","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/j.1440-1746.2008.05419.x","volume":"23","author":"A Andoh","year":"2008","unstructured":"Andoh A, Tsujikawa T, Ban H, et al. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2008;23:1373\u20137.","journal-title":"J Gastroenterol Hepatol."},{"key":"1831_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ijcp.12039","volume":"67","author":"M Smith","year":"2013","unstructured":"Smith M, Blaker P, Patel C, et al. The impact of introducing thioguanine nucleotide monitoring into an inflammatory bowel disease clinic. Int J Clin Pract. 2013;67:161\u20139.","journal-title":"Int J Clin Pract."},{"key":"1831_CR28","doi-asserted-by":"crossref","unstructured":"Ribeiro AC, Gerheim PSAS, Chebli JMF, Nascimento JWL, Faria PP. The role of pharmacogenetics in the therapeutic response to thiopurines in the treatment of inflammatory bowel disease: a systematic review. J Clin Med. 2023;12:6742.","DOI":"10.3390\/jcm12216742"},{"key":"1831_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/jgh.13210","volume":"31","author":"R Goldberg","year":"2016","unstructured":"Goldberg R, Moore G, Cunningham G, et al. Thiopurine metabolite testing in inflammatory bowel disease. J Gastroenterol Hepatol. 2016;31:553\u201360.","journal-title":"J Gastroenterol Hepatol."}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01831-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01831-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01831-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:33:15Z","timestamp":1778484795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01831-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1831"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01831-2","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KGU, MBD, DCD, PRN, SAVS, MUP, SDP, PA, SGK, NDD, DNS, TFA and AJD\u00a0declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}